• Explore /
  • Poster
  • / Meta-analysis of randomized clinical trials (RCT) for the adjuvant treatment of high-risk clear cell renal carcinoma (RCC) with vascular endothelial growth factor receptor tyrosine-kinase inhibitors (VEGFR TKIs).

Meta-analysis of randomized clinical trials (RCT) for the adjuvant treatment of high-risk clear cell renal carcinoma (RCC) with vascular endothelial growth factor receptor tyrosine-kinase inhibitors (VEGFR TKIs).

Abstract Poster

Authors

Daniel Vargas Pivato de Almeida

Daniel Vargas Almeida

A Beneficencia Portuguesa de Sao Paulo: BP, São Paulo, Brazil

Daniel Vargas Almeida , Cleyton Z. Oliveira , Andrey Soares , Denis L Jardim , Diogo Assed Bastos , Fernando C. Maluf , Gustavo Werutsky , Fernando Sabino M Monteiro , Vinicius Carrera Souza , Andre Poisl Fay , Fabio A. B. Schutz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer

Track

Renal Cell Cancer

Sub Track

Renal Cell Cancer

Citation

J Clin Oncol 36, 2018 (suppl 6S; abstr 660)

DOI

10.1200/JCO.2018.36.6_suppl.660

Abstract #

660

Poster Bd #

J11

Abstract Disclosures

Similar Posters

First Author: Daniel Vargas Almeida

First Author: Christopher J. Richards

Poster

2020 Genitourinary Cancers Symposium

Adjuvant therapy in high-risk renal cell cancer: A systematic review and cumulative meta-analysis.

Adjuvant therapy in high-risk renal cell cancer: A systematic review and cumulative meta-analysis.

First Author: Rabbia Siddiqi

First Author: Irbaz Bin Riaz